Headlines

Viking Therapeutics Soars 26.5% At Opening Bell On Tuesday

About Viking Therapeutics Viking Therapeutics is a clinical-stage biopharmaceutical company, focused on the creation of innovative treatments for metabolic and endocrine conditions. VK2809, their lead drug candidate, is a tissue and receptor subtype selective agonist of thyroid hormone receptor beta currently in Phase IIb clinical trials for treating nonalcoholic steatohepatitis and nonalcoholic fatty liver disease…

Read More